Delphi Diagnostics Inc.
0 followers
‌
Delphi Diagnostics provide delphi’s sensitivity to endocrine therapy. It is a gene expression interpretive algorithm that measures potential disease progression on endocrine therapy in patients with hormone receptor positive HER2 negative breast cancer.
Industries
Headquarters
Employees
Links
Org chart
Winz Casagrande
CEO & Chair
Winz Casagrande
Collapse
Emily Granger
Director, Marketing
Hansjuergen Overstolz
Chief Financial Officer & Member of Board of Directors
J. Chuck Morrison
Chief Commercial Officer (CCO)
Nyrie Toukmanian
Director, Corporate Communications & Administration
Federico A Monzon
Chief Medical Officer
